0001104659-18-041349.txt : 20180620
0001104659-18-041349.hdr.sgml : 20180620
20180620194258
ACCESSION NUMBER: 0001104659-18-041349
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180620
FILED AS OF DATE: 20180620
DATE AS OF CHANGE: 20180620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: New Leaf Venture Management III, L.L.C.
CENTRAL INDEX KEY: 0001625657
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38535
FILM NUMBER: 18910598
BUSINESS ADDRESS:
STREET 1: C/O NEW LEAF VENTURE PARTNERS
STREET 2: 7 TIMES SQUARE, SUITE 3502
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 646-871-6400
MAIL ADDRESS:
STREET 1: C/O NEW LEAF VENTURE PARTNERS
STREET 2: 7 TIMES SQUARE, SUITE 3502
CITY: NEW YORK
STATE: NY
ZIP: 10036
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: New Leaf Venture Associates III, L.P.
CENTRAL INDEX KEY: 0001625656
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38535
FILM NUMBER: 18910599
BUSINESS ADDRESS:
STREET 1: C/O NEW LEAF VENTURE PARTNERS
STREET 2: 7 TIMES SQUARE, SUITE 3502
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 646-871-6400
MAIL ADDRESS:
STREET 1: C/O NEW LEAF VENTURE PARTNERS
STREET 2: 7 TIMES SQUARE, SUITE 3502
CITY: NEW YORK
STATE: NY
ZIP: 10036
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: New Leaf Ventures III, L.P.
CENTRAL INDEX KEY: 0001625653
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38535
FILM NUMBER: 18910600
BUSINESS ADDRESS:
STREET 1: C/O NEW LEAF VENTURE PARTNERS
STREET 2: 7 TIMES SQUARE, SUITE 3502
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 646-871-6400
MAIL ADDRESS:
STREET 1: C/O NEW LEAF VENTURE PARTNERS
STREET 2: 7 TIMES SQUARE, SUITE 3502
CITY: NEW YORK
STATE: NY
ZIP: 10036
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: New Leaf Biopharma Opportunities I, L.P.
CENTRAL INDEX KEY: 0001625696
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38535
FILM NUMBER: 18910601
BUSINESS ADDRESS:
STREET 1: C/O NEW LEAF VENTURE PARTNERS
STREET 2: 7 TIMES SQUARE, SUITE 3502
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 646-871-6400
MAIL ADDRESS:
STREET 1: C/O NEW LEAF VENTURE PARTNERS
STREET 2: 7 TIMES SQUARE, SUITE 3502
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER NAME:
FORMER CONFORMED NAME: New Leaf Growth Fund I, L.P.
DATE OF NAME CHANGE: 20141117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: New Leaf BPO Associates I, L.P.
CENTRAL INDEX KEY: 0001625693
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38535
FILM NUMBER: 18910602
BUSINESS ADDRESS:
STREET 1: C/O NEW LEAF VENTURE PARTNERS
STREET 2: 7 TIMES SQUARE, SUITE 3502
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 646-871-6400
MAIL ADDRESS:
STREET 1: C/O NEW LEAF VENTURE PARTNERS
STREET 2: 7 TIMES SQUARE, SUITE 3502
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER NAME:
FORMER CONFORMED NAME: New Leaf Growth Associates I, L.P.
DATE OF NAME CHANGE: 20141117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptinyx Inc.
CENTRAL INDEX KEY: 0001674365
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474626057
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 MAPLE AVENUE
STREET 2: SUITE 4300
CITY: EVANSTON
STATE: IL
ZIP: 60201
BUSINESS PHONE: 847-871-0377
MAIL ADDRESS:
STREET 1: 909 DAVIS STREET
STREET 2: SUITE 600
CITY: EVANSTON
STATE: IL
ZIP: 60201
3
1
a3.xml
3
X0206
3
2018-06-20
0
0001674365
Aptinyx Inc.
APTX
0001625657
New Leaf Venture Management III, L.L.C.
C/O NEW LEAF VENTURES
7 TIMES SQUARE, SUITE 3502
NEW YORK
NY
10036
0
0
1
0
0001625656
New Leaf Venture Associates III, L.P.
C/O NEW LEAF VENTURES
7 TIMES SQUARE, SUITE 3502
NEW YORK
NY
10036
0
0
1
0
0001625653
New Leaf Ventures III, L.P.
C/O NEW LEAF VENTURES
7 TIMES SQUARE, SUITE 3502
NEW YORK
NY
10036
0
0
1
0
0001625696
New Leaf Biopharma Opportunities I, L.P.
C/O NEW LEAF VENTURES
7 TIMES SQUARE, SUITE 3502
NEW YORK
NY
10036
0
0
1
0
0001625693
New Leaf BPO Associates I, L.P.
C/O NEW LEAF VENTURES
7 TIMES SQUARE, SUITE 3502
NEW YORK
NY
10036
0
0
1
0
Series A-1 Convertible Preferred Stock
Common Stock
1047450
I
See footnotes
Series A-2 Convertible Preferred Stock
Common Stock
1197076
I
See footnotes
Series B Convertible Preferred Stock
Common Stock
552208
I
See footnotes
Series B Convertible Preferred Stock
Common Stock
243345
I
See footnote
All series of convertible preferred stock will automatically convert into the number of shares of the Issuer's common stock on a 27.58621-for-1 basis immediately prior to the closing of the Issuer's initial public offering and have no expiration date.
These shares are held directly by New Leaf Ventures III, L.P. ("NLV-III"). The general partner of NLV-III is New Leaf Venture Associates III, L.P. ("NLVA-III"). The general partner of NLVA-III is New Leaf Venture Management III, L.L.C. ("Management-III"). Each of NLVA-III and Management-III disclaim beneficial ownership of these securities and this report shall not be deemed an admission that NLVA-III or Management-III are beneficial owners of such securities for purposes of Section 16 or any other purpose, except to the extent of their respective pecuniary interests therein. Ronald M. Hunt, Vijay K. Lathi, and Liam T. Ratcliffe, a member of the Issuer's board of directors, are the managers of Management-III (each, a "Manager" and collectively, the "Managers") and may each be deemed to have shared voting and investment power with respect to these securities.
Each of the Managers disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
These shares are held directly by New Leaf Ventures Biopharma Opportunities I, L.P. ("NLV Biopharma"). The general partner of NLV Biopharma is New Leaf BPO Associates I, L.P. ("NLBA-I"). The general partner of NLBA-I is Management-III. Each of NLVB-I and Management-III disclaim beneficial ownership of these securities and this report shall not be deemed an admission that NLVB-I or Management-III are beneficial owners of such securities for purposes of Section 16 or any other purpose, except to the extent of their respective pecuniary interests therein. The Managers may be deemed to have shared voting and investment power with respect to these securities. Each of the Managers disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
New Leaf Venture Management III, L.L.C. /s/ Craig Slutzkin By: Craig Slutzkin Its: Chief Financial Officer
2018-06-20
New Leaf Venture Associates III, L.P. By: New Leaf Venture Management III, L.L.C., its general partner /s/ Craig Slutzkin By: Craig Slutzkin Its: Chief Financial Officer
2018-06-20
New Leaf Ventures III, L.P. By: New Leaf Venture Associates III, L.P. By: New Leaf Venture Management III, L.L.C., its general partner /s/ Craig Slutzkin By: Craig Slutzkin Its: Chief Financial Officer
2018-06-20
New Leaf Ventures Biopharma Opportunities I, L.P. By: New Leaf BPO Associates I, L.P. By: New Leaf Venture Management III, L.L.C., its general partner /s/ Craig Slutzkin By: Craig Slutzkin Its: Chief Financial Officer
2018-06-20
New Leaf BPO Associates I, L.P. By: New Leaf Venture Management III, L.L.C., its general partner /s/ Craig Slutzkin By: Craig Slutzkin Its: Chief Financial Officer
2018-06-20